Trulieve (NASDAQ: TRUL) – Is This the Right Time to Buy Shares of Trulieve?
Trulieve is a growing company that has come a long way in the past few years. It has also become a big name in the industry. But with so much competition and the slow expansion that it has been experiencing, it may not be the best time to buy shares of the company.
Curaleaf Is Bigger Than Trulieve
Curaleaf is a growing company. The market cap is about $4.6 billion. It is in 23 states and has more than 136 dispensaries. Despite its growth, it needs new leadership. Trulieve is also expanding. But it has a smaller market share.
Curaleaf is a vertically integrated cannabis company that has a high focus on research and development. They’re acquiring companies in order to improve their portfolio. As a result, they have a higher share price.
When Curaleaf released its first quarter results last month, it said it experienced strong month-over-month sales. Analysts said the results beat estimates. However, the stock dropped 3%.
The company reported $317.1 million in revenue in the third quarter. That’s an increase of 8% year-over-year. However, it was down 1% sequentially.
Curaleaf’s net loss increased from $0.01 to $0.04 during the quarter. Analysts noted that it incurred “transient headwinds” during the period.
Curaleaf is expanding and investing in training. The company has 4.4 million square feet of cultivation capacity. This helps it take advantage of the East Coast’s recreational marijuana markets.
Growth Has Been Astronomical Since The Legislative Change
Trulieve’s growth has been staggering since the legislative change to legalize cannabis in Florida. In the first half of the year, the company reported $408.9 million in revenue. This was up from $308.2 million in the same period last year, which represents a 34% increase.
The largest number of Trulieve stores in the country are in Florida. But the company has also established hubs in the Southeast and Southwest. And now, it’s preparing for the day when marijuana is legalized in Florida for recreational use.
The company has been a leader in the medical marijuana industry. It was the first to cultivate medical marijuana, the first to sell smokable pot, and the first to deliver it. A recent survey showed that a large majority of Americans favor legalization.
Truelieve is on a quest to become the most dominant national player in the legalized cannabis industry. It is already the biggest in Florida, and it is working on expanding nationwide.
Company’s Slow Expansion May Be A Disadvantage For Investors
Trulieve (NASDAQ: TRUL) is a Florida based medical marijuana producer and dispensary operator. The company operates one-fourth of all medical marijuana dispensaries in the state. In September of 2018, the company acquired two medical marijuana dispensaries in Pennsylvania. It has also scored a processor permit from the state of West Virginia. Although the company has only scratched the surface of the Sunshine State, the statewide market is still relatively small. This is a boon for multistate operators looking to expand their customer base and grow sales.
Several companies are looking to take the helm in the booming cannabis industry. Cresco Labs (NASDAQ: CRLBF), Trulieve and Green Thumb Industries (GTBIF) are the creme de la creme. However, these firms have different goals and are not necessarily suited for the same market. For example, Trulieve is primarily a single state medical marijuana operation and is best suited for the statewide market, while Cresco Labs is in a much more lucrative business.
125 Questions People Have Asked About Working At Trulieve
There are a lot of different questions that people have asked about Trulieve. From the company’s preferred physicians to the most commonly asked questions about medical cannabis, there is a lot to learn about the company. Here is an overview of the company and what it’s like to work for it.
While Trulieve has experienced some challenges in opening its stores and getting new products out to market, the company is committed to making the medical cannabis buying process easier for consumers. The website lists the most common questions patients have about the plant, and offers a list of preferred physicians. You can even visit one of the stores if you need help finding a physician.
Trulieve’s employee average is slightly higher than the average at other similar companies, but it’s not as high as the average at Nature’s Medicines. Depending on the job you have, you can make between $26,000 and $89,000 per year. But there are also a lot of people who earn less than this at the company.
